Skip to content

Effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in patients with chronic tinnitus.

Effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in patients with chronic tinnitus. - Treatment of tinnitus with rTMS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31727
Enrollment
52
Registered
2007-12-11
Start date
2008-07-21
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phantom auditory perception ringing in the ear

Interventions

In the intervention group neuronavigated rTMS will be applied bilaterally to the auditory cortices, which will be identified through a structural MRI scan. Stimulation will be performed with 1Hz fre

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronic non fluctuating tinnitus, demonstrated tinnitus by means of the Diagnostic Protocol Tinnitus UMCU, without a treatable cause of at least two months duration Age 18 years or older

Exclusion criteria

Exclusion criteria: Treatable cause of the tinnitus Use of anticonvulsant drugs or psychotherapeutic drugs which lower the seizure threshold History of epilepsy or family members with epilepsy Presence of active migraine Presence of structural brain changes Presence of psychiatric disease Presence of severe internal or heart diseases Metal objects in or around body that cannot be removed Metal workers Pregnancy (will be tested on the first day of TMS with a urine pregnancy test) Drugs or alcohol abuse Prior treatment with TMS

Design outcomes

Primary

MeasureTime frame
The main study parameter is the tinnitus severity measured by the Tinnitus Questionnaire.

Secondary

MeasureTime frame
The secondary study parameter investigates whether (in case of positive results with rTMS) tinnitus characteristics (frequency, loudness, minimal masking level, residual inhibition) change. The change in these tinnitus characteristics will be measured with the tinnitus analysis

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)